Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants and young children
AssigneeSociete des Produits Nestle S.A.
InventorPer Torp Sangild
Life of this patent
Estimating the term…
Abstract
The invention discloses a composition comprising LNT and at least another human milk oligosaccharide or precursor thereof, for use in preventing and/or treating necrotizing enterocolitis in infants and young children.
Claims13
A method for treating necrotizing enterocolitis and/or decreasing incidence of necrotizing enterocolitis in an infant or young child in need thereof, the method comprising administering to the infant or young child a composition comprising 2′-fucosyllactose (2-FL), 6′ sialyllactose (6-SL), and N-acetylated oligosaccharides comprising lacto-N-tetraose (LNT) and lacto-N-neotetraose (LNnT) in a ratio of LNT:LNnT between 2:1 and 1:1, wherein the LNT is present in an amount from 0.4 to 2 g/L of the composition, and the 2′-fucosyllactose (2-FL), the 6′sialyllactose (6-SL), the lacto-N-tetraose (LNT) and the lacto-N-neotetraose (LNnT) are the only human milk oligosaccharides in the composition.
Dependencies are inferred from the claim text.